Malaria Journal

official impact factor 3.49

Open Access Highly Access

Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis

Julien Zwang*, Piero Olliaro, Hubert Barennes, Maryline Bonnet, Philippe Brasseur, Hasifa Bukirwa, Sandra Cohuet, Umberto D'Alessandro, Abdulaye Djimdé, Corine Karema, Jean-Paul Guthmann, Sally Hamour, Jean-Louis Ndiaye, Andreas Mårtensson, Claude Rwagacondo, Issaka Sagara, Albert Same-Ekobo, Sodiomon B Sirima, Ingrid van den Broek, Adoke Yeka, Walter RJ Taylor, Grant Dorsey and Milijaona Randrianarivelojosia

Malaria Journal 2009, 8:203 doi:10.1186/1475-2875-8-203

Accesses  

  • Last 30 days: 101 accesses
  • Last 365 days: 1169 accesses
  • All time: 5414 accesses

Cited by

BioMed Central: 2 citations

Research   Open Access

Comparing changes in haematologic parameters occurring in patients included in randomized controlled trials of artesunate-amodiaquine vs single and combination treatments of uncomplicated falciparum in sub-Saharan Africa

Julien Zwang, Jean-Louis Ndiaye, Abdoulaye Djimdé, Grant Dorsey, Andreas Mårtensson, Corine Karema, Piero Olliaro Malaria Journal 2012, 11:25 (25 January 2012)

Effect of different antimalarial treatments on haematologic parameters comparing artesunate-amodiaquine against various single treatment lines and combination therapies.

Research   Open Access Highly Accessed

Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial

Jean-Louis A Ndiaye, Babacar Faye, Ali Gueye, Roger Tine, Daouda Ndiaye, Corinne Tchania, Ibrahima Ndiaye, Aichatou Barry, Badara Cissé, Valérie Lameyre, Oumar Gaye Malaria Journal 2011, 10:237 (12 August 2011)

The paper tackles an important topic as there is a need for continuous evaluation of the safety and efficacy of ACT in malaria endemic areas.